Company Overview of Arradial, Inc.
As per the transaction announced in December 2002, Arradial, Inc. was acquired by BioProcessors Corp. Arradial, Inc. is a biopharmaceutical company that develops silicon-based platforms for ultra high-throughput screening applications in genomics and drug discovery. The company’s proprietary microfluidics-based platform combines discovery automation with cellular biology and information technology thus allowing drug screening against novel drug targets, cell lines, and tissues. Arradial, Inc. was founded in November 2000 and is based in Bedford, Massachusetts.
8 Preston Court
Bedford, MA 01730
Founded in 2000
Key Executives for Arradial, Inc.
Arradial, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Vectoris Pharma LLC||United States|
|eFFECTOR Therapeutics, Inc.||United States|
|Caisson Biotech, LLC||United States|
|QRS Heart, Inc.||United States|
|Venture Biodiscovery, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Arradial, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.